Q4 2023 Cytokinetics Inc Earnings Call Transcript
Good afternoon and welcome ladies and gentlemen to Cytokinetics Fourth Quarter 2023 conference call. (Operator instructions) I will now turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communication, and Investor Relations. Please go ahead.
Good afternoon and thanks for joining us on the call today. Robert Blum, President, and Chief Executive Officer will begin with an overview of the quarter and recent development. Fady Malik, EVP of R&D will provide updates related to aficamten focus to SEQUOIA-HCM and FOREST-HCM. Stuart Kupfer, SVP and Chief Medical Officer will provide additional updates for aficamten relating to ACACIA-HCM and MAPLE-HCM and will also discuss CK-586 and CK-136. Andrew Callos, EVP, and Chief Commercial Officer will speak about commercial readiness activities for aficamten . Robert Wong, VP and Chief Accounting Officer, will provide a financial overview of the past quarter. And finally, Robert Blum will discuss our 2024
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |